Next 10 |
2024-07-03 11:11:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips For most of the year, biotech has been one of the most explosive sectors on the market. Far from over, further upside is likely, thanks to some of the top biotech stocks with catalysts. ...
2024-07-03 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The personalized medicine market is experiencing significant growth, driven by advancements in genomic technologies and a shift towards more individualized healthcare . In 2024, the market ...
2024-07-02 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The bottom line about the stock market is that it is a popularity contest. That’s because there is no one true way to determine the exact value of a stock. Despite this, financial instit...
2024-06-21 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-11 13:45:23 ET Summary We are revisiting oncology testing company Exact Sciences Corporation today for the first time in nearly a year and a half. The shares have been cut by more than half since last summer, despite revenue growth in the low teens and strong support from ...
2024-06-06 09:50:33 ET Summary Guardant Health's stock has curled up from lows in the last six months. The FDA panel approved GH's Shield blood test, resulting in a positive announcement drift to the upside. Q1 2024 earnings showed strong growth, revised guidance, and increase...
Upgraded gene panel on tissue genomic profiling test covers 498 biomarkers, including guideline-recommended genes Operational improvements streamline workflow and shorten time to results Upgraded test covered by Medicare for comprehensive genomic profiling of all advanced solid tu...
2024-06-04 07:00:06 ET Kyle Mikson from Canaccord Genuity issued a price target of $38.00 for GH on 2024-06-04 05:20:00. The adjusted price target was set to $38.00. At the time of the announcement, GH was trading at $27.41. The overall price target consensus is at $58.2...
Data from study using Guardant360® blood test show Black patients with PIK3CA mutations in advanced breast cancer were less likely than White patients to be enrolled in clinical trials and receive targeted therapy Study is part of collaboration between Guardant Health and Multicenter...
Guardant’s Impact, Innovation, Ambition, and Success Contributed to the Recognition Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced its inclusion in the fourth-annual TIME100 Most Influential Companies list, highlighting companies making...
News, Short Squeeze, Breakout and More Instantly...